Lymphoma, T-Cell, Cutaneous

"Lymphoma, T-Cell, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES; SEZARY SYNDROME; LYMPHOMATOID PAPULOSIS; and PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA are the best characterized of these disorders.

Descriptor ID	D016410
MeSH Number(s)	C04.557.386.480.750.800 C15.604.515.569.480.750.800 C20.683.515.761.480.750.800
Concept/Terms	Lymphoma, T-Cell, Cutaneous Lymphoma, T-Cell, Cutaneous T-Cell Lymphoma, Cutaneous T Cell Lymphoma, Cutaneous Cutaneous T-Cell Lymphoma Cutaneous T Cell Lymphoma Cutaneous T-Cell Lymphomas Lymphoma, Cutaneous T-Cell Lymphomas, Cutaneous T-Cell T-Cell Lymphomas, Cutaneous Lymphoma, T Cell, Cutaneous Granulomatous Slack Skin Granulomatous Slack Skin Slack Skin, Granulomatous

Below are MeSH descriptors whose meaning is more general than "Lymphoma, T-Cell, Cutaneous".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Lymphoma, Non-Hodgkin [C04.557.386.480]
Lymphoma, T-Cell [C04.557.386.480.750]
Lymphoma, T-Cell, Cutaneous [C04.557.386.480.750.800]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Lymphoma, Non-Hodgkin [C15.604.515.569.480]
Lymphoma, T-Cell [C15.604.515.569.480.750]
Lymphoma, T-Cell, Cutaneous [C15.604.515.569.480.750.800]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Lymphoma, Non-Hodgkin [C20.683.515.761.480]
Lymphoma, T-Cell [C20.683.515.761.480.750]
Lymphoma, T-Cell, Cutaneous [C20.683.515.761.480.750.800]

Below are MeSH descriptors whose meaning is related to "Lymphoma, T-Cell, Cutaneous".

Below are MeSH descriptors whose meaning is more specific than "Lymphoma, T-Cell, Cutaneous".

Lymphoma, T-Cell, Cutaneous
Lymphoma, Primary Cutaneous Anaplastic Large Cell
Lymphomatoid Papulosis
Mycosis Fungoides
Sezary Syndrome

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoma, T-Cell, Cutaneous" by people in this website by year, and whether "Lymphoma, T-Cell, Cutaneous" was a major or minor topic of these publications.

Bar chart showing 9 publications over 9 distinct years, with a maximum of 1 publications in 1994 and 2003 and 2004 and 2012 and 2014 and 2018 and 2020 and 2021 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	0	1
2003	1	0	1
2004	1	0	1
2012	0	1	1
2014	1	0	1
2018	1	0	1
2020	1	0	1
2021	1	0	1
2022	1	0	1

Below are the most recent publications written about "Lymphoma, T-Cell, Cutaneous" by people in Profiles.

Kim EJ, Mangold AR, DeSimone JA, Wong HK, Seminario-Vidal L, Guitart J, Appel J, Geskin L, Lain E, Korman NJ, Zeitouni N, Nikbakht N, Dawes K, Akilov O, Carter J, Shinohara M, Kuzel TM, Piette W, Bhatia N, Musiek A, Pariser D, Kim YH, Elston D, Boh E, Duvic M, Huen A, Pacheco T, Zwerner JP, Lee ST, Girardi M, Querfeld C, Bohjanen K, Olsen E, Wood GS, Rumage A, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH, Poligone B. Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2022 09 01; 158(9):1031-1039.

View in: PubMed
Trum NA, Zain J, Martinez XU, Parekh V, Afkhami M, Abdulla F, Carson KR, Rosen ST, Bennett CL, Querfeld C. Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series. Br J Dermatol. 2022 01; 186(1):153-166.

View in: PubMed
Elston DM. Dupilumab and cutaneous T-cell lymphoma. J Am Acad Dermatol. 2020 07; 83(1):33-34.

View in: PubMed
Chou CF, Hsieh YH, Grubbs CJ, Atigadda VR, Mobley JA, Dummer R, Muccio DD, Eto I, Elmets CA, Garvey WT, Chang PL. The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis. J Dermatol Sci. 2018 Jun; 90(3):343-356.

View in: PubMed
Jacks SM, Taylor BR, Rogers RP, Ralston JS, Metcalf JS, Lazarchick J. Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti') lymphoma after administration of adalimumab. J Am Acad Dermatol. 2014 Sep; 71(3):e86-7.

View in: PubMed
Dalton SR, Chandler WM, Abuzeid M, Hossler EW, Ferringer T, Elston DM, LeBoit PE. Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages. Am J Dermatopathol. 2012 Aug; 34(6):586-91.

View in: PubMed
Shani-Adir A, Lucky AW, Prendiville J, Murphy S, Passo M, Huang FS, Paller AS. Subcutaneous panniculitic T-cell lymphoma in children: response to combination therapy with cyclosporine and chemotherapy. J Am Acad Dermatol. 2004 Feb; 50(2 Suppl):S18-22.

View in: PubMed
Kotz EA, Anderson D, Thiers BH. Cutaneous T-cell lymphoma. J Eur Acad Dermatol Venereol. 2003 Mar; 17(2):131-7.

View in: PubMed
Jörg B, Kerl H, Thiers BH, Bröcker EB, Burg G. Therapeutic approaches in cutaneous lymphoma. Dermatol Clin. 1994 Apr; 12(2):433-41.

View in: PubMed

People

Explore

Similar Concepts

Top Journals